Autor: "Riviere, Cynthia" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
Autorzy:: Dorvil N; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Rivera VR; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Riviere C; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Berman R; The Analysis Group, Boston, Massachusetts, United States of America.
Severe P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Bang H; University of California, Davis School of Medicine, Davis, California, United States of America.
Lavoile K; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Devieux JG; Florida International University, Miami, Florida, United States of America.
Faustin M; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Saintyl G; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Mendicuti MD; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Pierre S; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Apollon A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Dumond E; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Forestal GPL; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Rouzier V; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America.
Marcelin A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
McNairy ML; Weill Cornell Medicine, New York, New York, United States of America.
Walsh KF; Weill Cornell Medicine, New York, New York, United States of America.
Dupnik K; Weill Cornell Medicine, New York, New York, United States of America.
Reif LK; Weill Cornell Medicine, New York, New York, United States of America.
Byrne AL; St. Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Bousleiman S; The Analysis Group, Boston, Massachusetts, United States of America.
Orvis E; The Analysis Group, Boston, Massachusetts, United States of America.
Joseph P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Cremieux PY; The Analysis Group, Boston, Massachusetts, United States of America.
Pape JW; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America.
Koenig SP; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2023 Jun 09; Vol. 20 (6), pp. e1004246. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2023).
Typ publikacji:: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/complications
HIV Infections*/diagnosis
HIV Infections*/drug therapy
Tuberculosis*/complications
Tuberculosis*/diagnosis
Tuberculosis*/drug therapy
Adult ; Humans ; Haiti/epidemiology ; RNA